Climb Bio
Most recent annual filing: 2026-03-05
- Budoprutug Ph1 interim2H 2026Budoprutug Ph1 interim, 2H 2026, material
- CLYM litigation ruling3Q 2026CLYM litigation ruling, 3Q 2026, routine
- Budoprutug Ph2 topline4Q 2026Budoprutug Ph2 topline, 4Q 2026, thesis-defining
- Budoprutug SC formulation Ph1 readout4Q 2026Budoprutug SC formulation Ph1 readout, 4Q 2026, material
Bar width shows how precise the guidance is — a pin is a stated date, a wide band a six-month window. Deeper blue means more of the thesis rides on the event; it is not a view on the stock.
Pipeline (7 active programs)
Biotech Distilled coverage (7)
- 2026-09-03 UPDATE: Climb Bio (CLYM) - The Sweeper Delivers Its Number 🔒 Paid
- 2026-08-07 UPDATE: Climb Bio (CLYM) - The Sweeper Gets a Date 🔒 Paid
- 2026-06-11 UPDATE: Climb Bio (CLYM) - The ITP Bar Clears
- 2026-06-05 UPDATE: Climb Bio (CLYM) - The Sweeper Clears Its First Bar
- 2026-05-06 UPDATE: Climb Bio (CLYM) - The SC Wedge Lands 🔒 Paid
- 2026-04-29 UPDATE: Climb Bio (CLYM) - The Smart Money Doubles Down 🔒 Paid
- 2026-04-23 Climb Bio (CLYM) - Scientific Deep Dive for Budoprutug and Pipeline Products 🔒 Paid
Articles open on Substack. Some are subscriber-only; those marked ★ Distilled Pro are for Distilled Pro members.